Biomedical Bonding Gains Funding for Bonevolent Fracture Treatment

Biomedical Bonding (BMB) has secured SEK 3 million (~USD $0.3 million) in funding to fast-track the development of their composite-based universal bone fixators for fracture treatment.

"BMB’s quest is to become the first MedTech company to provide implants that adapt to fractures in real-time during surgery, as opposed to pre-manufactured metal...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us